Viewing Study NCT06448533



Ignite Creation Date: 2024-06-16 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06448533
Status: COMPLETED
Last Update Posted: 2024-06-07
First Post: 2024-06-02

Brief Title: The Predictive Value of Prostate Spherical Volume Ratio in Lower Urinary Tract Symptoms and Clinical Progression of Benign Prostatic HyperplasiaA Single-center Paired Validating Confirmatory Study
Sponsor: Shanghai East Hospital
Organization: Shanghai East Hospital

Study Overview

Official Title: The Predictive Value of Prostate Spherical Volume Ratio in Lower Urinary Tract Symptoms and Clinical Progression of Benign Prostatic HyperplasiaA Single-center Paired Validating Confirmatory Study
Status: COMPLETED
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study was a retrospective cohort study clinical trial designed to assess the predictive ability of the prostate morphometric parameter Prostate Spherical Volume Ratio in the lower urinary tract symptoms and clinical progression of benign prostatic hyperplasia and to compare the predictive ability of other anatomical parameters of the prostate prostatic urethral length intravesical prostatic protrusion presumed circle area ratio and prostate volume in the lower urinary tract symptoms and clinical progression of benign prostatic hyperplasia
Detailed Description: This was a retrospective observational study approved by the Ethics Committee of Shanghai Oriental Hospital We collected patients with BPH who underwent MRI urine flow measurement and completed the IPSS questionnaire in our hospital between September 2022 and April 2023 measured each anatomical parameter of the patients prostate by MRI analysed the relationship of these prostate parameters with IPSS and urine flow and conducted a follow-up of the clinical progression of the prostate in these patients to evaluate the predictive efficacy of prostate parameters for LUTS and clinical progression of benign prostatic hyperplasia

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None